When a clinical trial shows patients losing an average of 15% of their body weight, that headline tends to overshadow a far more important question: what exactly are they losing? A landmark 2021 study published in the New England Journal of Medicine on semaglutide — the active ingredient in Ozempic and Wegovy — demonstrated dramatic weight loss results, but the body composition data buried in the supplementary figures told a more complicated story. Research from the STEP 1 trial showed that while participants lost substantial fat mass, a meaningful portion of the weight lost was lean mass — raising legitimate concerns for any man who cares not just about the number on the scale, but about the muscle underneath.
This isn’t a niche concern for bodybuilders. Muscle mass is one of the most powerful predictors of long-term metabolic health, insulin sensitivity, mobility, and even mortality risk. Losing it — regardless of how you’re losing weight, whether through caloric restriction, GLP-1 medications, or aggressive dieting — is a serious issue that deserves more than a footnote. So let’s look at what the science actually says about Ozempic, muscle loss, and what you can do about it.
What the Research Shows About Semaglutide and Lean Mass
To understand the muscle loss concern, you need to understand a fundamental truth about weight loss biology: when you create a significant caloric deficit — by any means — your body doesn’t selectively burn fat. It breaks down a mixture of fat, lean tissue, and in some cases bone mineral density. This is not unique to GLP-1 receptor agonists like semaglutide or tirzepatide. It happens with every aggressive diet. The question is always the ratio.
In the STEP 1 trial, participants lost roughly 15.3 kg on average over 68 weeks. Approximately 40% of that weight loss was lean mass, which is broadly consistent with what’s observed in other large-scale caloric restriction studies. A 2022 analysis in Diabetes, Obesity and Metabolism compared body composition changes across several GLP-1 trials and found that lean mass losses ranged from 25 to 39% of total weight lost — a range that spans outcomes seen in standard hypocaloric diets as well. In other words, Ozempic doesn’t appear to cause uniquely excessive muscle loss compared to other forms of weight loss, but it also doesn’t protect you from it.
What makes GLP-1-driven weight loss distinctive is the speed and magnitude. Because these medications can suppress appetite so dramatically, some users enter very deep caloric deficits without really trying — or even realizing it. A man eating 900 calories a day because he simply has no appetite is going to lose muscle faster than one eating 1,600 calories with a modest deficit. The drug isn’t destroying muscle directly; the inadequate protein intake and physical inactivity that often accompany aggressive appetite suppression are doing the damage. This distinction matters enormously for how you address the problem.
More recently, researchers have turned to tirzepatide — the dual GIP/GLP-1 agonist sold as Mounjaro — for comparison data. The SURMOUNT-1 trial reported weight losses exceeding 20%, and while lean mass losses were observed, the proportion of lean mass lost was similar to or slightly better than semaglutide. Neither drug appears to be uniquely muscle-wasting, but neither is muscle-sparing either — at least not without deliberate countermeasures.
Why Muscle Loss During Any Weight Loss Phase Is a Problem Worth Taking Seriously
It’s worth stepping back from the Ozempic-specific conversation to understand why this matters for every man trying to get leaner — with or without medication. Skeletal muscle is metabolically expensive tissue. It drives resting energy expenditure, acts as the primary sink for dietary glucose, and produces myokines — signaling proteins that have anti-inflammatory and metabolic benefits throughout the body. Research consistently links higher muscle mass to reduced risk of type 2 diabetes, cardiovascular disease, and all-cause mortality.
When you lose significant lean mass during a weight loss phase, you also lower your basal metabolic rate — meaning you burn fewer calories at rest. This sets the stage for the classic weight regain cycle: the deficit required to keep losing gets smaller and smaller, adherence breaks down, and the weight comes back — but the muscle doesn’t return on its own. You end up at a similar body weight but with a worse body composition than before. This phenomenon, sometimes called “skinny fat” rebound, is one of the most frustrating outcomes in weight management and it’s far more common than most diet programs acknowledge.
For men on GLP-1 medications, this risk is compounded by the fact that appetite suppression can lead to chronically low protein intake. Protein is the nutritional substrate for muscle protein synthesis — the process by which your body builds and repairs muscle tissue. Studies show that protein intakes of at least 1.6 grams per kilogram of body weight per day are necessary to preserve lean mass during caloric restriction, and many men in aggressive deficits — medicated or not — fall well short of that target. When your appetite is chemically suppressed, hitting even 100 grams of protein a day can feel like a challenge.
How to Preserve Muscle While Losing Fat — Regardless of Your Method
The good news is that the strategies for preserving muscle during weight loss are well-established and work whether you’re on Ozempic, following a ketogenic diet, doing intermittent fasting, or simply eating in a modest caloric deficit. The fundamentals don’t change based on how you’re creating the deficit.
Resistance training is the single most important intervention. A meta-analysis in the British Journal of Sports Medicine found that combining resistance training with caloric restriction preserved significantly more lean mass than caloric restriction alone — regardless of the magnitude of the deficit. Lifting weights sends a powerful anabolic signal to your muscles: you need this tissue, don’t break it down. For men on GLP-1 medications who may be less active due to fatigue or reduced food motivation, this signal becomes even more critical. Aim for at least three sessions per week of progressive resistance training, prioritizing compound movements like squats, deadlifts, rows, and presses that stimulate the largest muscle groups.
Protein intake deserves equal emphasis. When appetite is suppressed, you need to be intentional — even strategic — about getting enough. Prioritizing high-protein foods first in any meal, using protein shakes as a tool when whole food intake is low, and tracking intake for at least a few weeks to establish awareness are all practical approaches. Research supports a target of 1.6 to 2.2 grams of protein per kilogram of body weight during active fat loss phases. For a 200-pound man, that translates to roughly 145 to 200 grams of protein daily — a number that requires real planning when appetite is blunted.
The rate of weight loss also matters more than most people realize. Research published in the International Journal of Sport Nutrition and Exercise Metabolism found that slower rates of weight loss — around 0.5 to 1% of body weight per week — resulted in significantly better lean mass retention compared to more aggressive cuts. For GLP-1 users who are losing two to three pounds per week consistently, it may be worth discussing with their prescriber whether a dose adjustment or dietary recalibration makes sense — not to slow the medication, but to ensure total caloric intake isn’t falling below functional thresholds.
Creatine monohydrate is one supplement with a genuinely strong evidence base in this context. Meta-analyses show that creatine supplementation combined with resistance training produces greater gains in lean mass and strength compared to resistance training alone. It’s inexpensive, safe, and has decades of research behind it. For men trying to hold onto or build muscle during a fat loss phase — on any protocol — it’s a rational addition. Three to five grams daily is the standard effective dose, with no loading phase required.
Sleep and stress management round out the picture in ways that rarely get enough attention. A study in the Annals of Internal Medicine demonstrated that sleep-restricted dieters lost significantly more lean mass and less fat mass than those sleeping adequately, even with identical caloric intakes. Cortisol — elevated by poor sleep and chronic stress — is catabolic to muscle tissue and promotes fat storage, particularly visceral fat. If you’re doing everything right in the gym and kitchen but running on five hours of sleep, you are actively working against your own physiology.
The Takeaway
Ozempic and other GLP-1 medications do not cause muscle loss in any unique or disproportionate way compared to other methods of significant weight loss. What they do is create the conditions — deep caloric deficits, reduced appetite, sometimes reduced activity — that make muscle loss more likely if you’re not proactively countering it. The drug isn’t the villain. Passive weight loss is.
Whether you’re using semaglutide, tirzepatide, or simply cutting carbs and hitting the gym harder, the principles are identical: lift heavy and consistently, eat enough protein to support muscle protein synthesis, lose weight at a sustainable rate, sleep enough, and manage your stress. These aren’t GLP-1 tips or bodybuilder tips — they are the non-negotiable foundations of body recomposition for any man at any stage of his health journey. The men who understand this will come out of any weight loss phase stronger, leaner, and metabolically healthier than when they started. The men who don’t will lose weight and wonder why they still don’t look or feel the way they expected.